Current Rheumatology Reports

, Volume 6, Issue 4, pp 317–321 | Cite as

Magnetic resonance imaging of psoriatic arthritis: Insight from traditional and three-dimensional analysis

  • Saara M. S. Totterman


The magnetic resonance imaging (MRI) findings in psoriatic arthritis (PsA) are the same and at the same time different from those seen in other inflammatory arthritides. Synovial hypertrophy is seen on MRI in all arthritides. However, the location and extent of bone marrow edema in PsA is different from those seen in rheumatoid arthritis (RA) and osteoarthritis. Progression studies in PsA are hard to justify. However, treatment monitoring studies have given insight into the pattern of progression of the MRI findings and information regarding the mechanism of the effect of the drugs used for treatment. Threedimensional image analysis tools provide volumetric information and information regarding the spatial and temporal relationship between different MRI findings. The three-dimensional perfusion image analysis tool, which is used to evaluate the effect of antiangiogenic drugs in cancer treatment, can provide information regarding the disease mechanism when used in disease monitoring studies.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Jorgensen C, Cyteval J, Anaya J, et al.: Sensitivity of magnetic resonance imaging of the wrist in very early rheumatoid arthritis. Clin Exp Rheumatol 1993, 11:163–168.PubMedGoogle Scholar
  2. 2.
    Waterton J, Rajanayagam V, Ross B, et al.: Magnetic resonance methods for measurements of disease progression in rheumatoid arthritis. Magn Reson Imaging 1993, 11:1033–1038.PubMedCrossRefGoogle Scholar
  3. 3.
    Yanagawa A, Takano K, Nishioka K, et al.: Clinical staging and gadolinium-DTPA enhanced images of the wrist in rheumatoid arthritis. J Rheumatol 1993, 20:781–784.PubMedGoogle Scholar
  4. 4.
    McGonagle D, Gibbon W, O’Connor P, et al.: Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum 1998, 41:694–700.PubMedCrossRefGoogle Scholar
  5. 5.
    Offidani A, Cellini A, Valeri G, Giovagnoni A: Subclinical joint involvement in psoriasis: magnetic resonance imaging and x-ray findings. Acta Derm Venereol 1998, 78:463–465.PubMedCrossRefGoogle Scholar
  6. 6.
    McQueen F, Stewart N, Crabbe J, et al.: Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis 1998, 58:156–163.CrossRefGoogle Scholar
  7. 7.
    Klarlund M, Østergaard M, Gideon P, et al.: Wrist and finger joint MR imaging in rheumatoid arthritis. Acta Radiol 1999, 40:400–409.PubMedCrossRefGoogle Scholar
  8. 8.
    Backhaus M, Kambradt T, Sandrock D, et al.: Arthritis of the finger joints. Arthritis Rheum 1999, 42:1232–1245.PubMedCrossRefGoogle Scholar
  9. 9.
    Queen F: Magnetic resonance imaging in early inflammatory arthritis: what is its role? Rheumatology 2000, 39:700–706.CrossRefGoogle Scholar
  10. 10.
    Savnik A, Malmskov H, Thomsen HS, et al.: Magnetic resonance imaging of the wrist and finger joints in patients with inflammatory joint disease. J Rheumatol 2001, 28:2193–2200. A clear illustration of the different MRI findings in arthritides.PubMedGoogle Scholar
  11. 11.
    Rand T, Imhof C, Breitenseher M, et al.: Discrimination between fluid, synovium, and cartilage in patients with rheumatoid arthritis: contrast enhanced spin echo versus non-contrast enhanced fat-suppressed gradient echo MR imaging. Clin Radiol 1999, 54:107–110.PubMedCrossRefGoogle Scholar
  12. 12.
    McGonagle D, Marzo-Ortega H, O’Connor P, et al.: The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy. Arthritis Rheum 2002, 46:489–493. This paper presents the different mechanisms causing BME and soft tissue edema.PubMedCrossRefGoogle Scholar
  13. 13.
    Klarlund M, Ostergaard M, Rostrup E, et al.: Dynamic magnetic resonance imaging of the metacarpophalangeal joints in rheumatoid arthritis, early unclassified polyarthritis, and healthy controls. Scand J Rheumatol 2000, 29:108–115.PubMedCrossRefGoogle Scholar
  14. 14.
    Munk P, Vellet A, Levin M, et al.: Intravenous administration of gadolinium in the evaluation of rheumatoid arthritis of the shoulder. J Can Assoc Radiol 1993, 44:99–106.Google Scholar
  15. 15.
    Ejbjerg B, Narvestad E, Rostrup E, et al.: Magnetic resonance imaging of wrist and finger joints in healthy subjects shows changes resembling erosions and synovitis as seen in rheumatoid arthritis. Arthritis Rheum 2004, 50:1097–1106.PubMedCrossRefGoogle Scholar
  16. 16.
    Felson D, McLaughlin S, Goggins J, et al.: Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med 2003, 139:330–336.PubMedGoogle Scholar
  17. 17.
    McQueen F, Benton N, Perry D, et al.: Bone edema scored on magnetic resonance scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later on patients with rheumatoid arthritis. Arthritis Rheum 2003, 48:1814–1827. This paper presents clear definitions for different MRI findings in arthritides.PubMedCrossRefGoogle Scholar
  18. 18.
    Zanetti M, Bruder E, Romero J, Hodler J: Bone marrow edema pattern in ostearhritic knees; correlation between MR imaging and histological findings. Radiology 2000, 215:835–840. This paper presents a correlation between BME and histology.PubMedGoogle Scholar
  19. 19.
    Marzo-Ortega H: Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy. Arthritis Rheum 2001, 44:2112–2117.PubMedCrossRefGoogle Scholar
  20. 20.
    Annandarajah A, Cangelosi C, Seo G-S, et al.: Evaluation of and scoring method in psoriatic arthritis: a pilot study. Arthritis Rheum 2003, 49:3645.Google Scholar
  21. 21.
    Jaffe I: New approaches to the management of rheumatoid arthritis. J Rheumatol 1992, 19:2–8.Google Scholar
  22. 22.
    Link T, Steinbach L, Gchosh S, et al.: Ostearthritis: MR imaging findings in different stages of diseases and the correlation with clinical findings. Radiology 2003, 226:373–381.PubMedCrossRefGoogle Scholar
  23. 23.
    Østergaard M, Gideon P, Sørensen K, et al.: Scoring of synovial membrane hypertrophy and bone erosions by MR imaging in clinically active and inactive rheumatoid arthritis of the wrist. Scand J Rheumatol 1995, 24:212–218.PubMedGoogle Scholar
  24. 24.
    Ostergaard M, Stoltenberg M, Gideon P, et al.: Changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone. Quantitative assessment of inflammatory and destructive changes in arthritis by MRI. J Rheumatol 1996, 23:1151–1161.PubMedGoogle Scholar
  25. 25.
    Ostergaard M, Hansen M, Stoltenberg M, Lorenzen I: Quantitative assessment of synovial membrane in the rheumatoid wrist: an easily obtained MRI score reflects the synovial volume. Br J Rheumatol 1996, 35:965–971.PubMedCrossRefGoogle Scholar
  26. 26.
    Ostergaard M: Different approaches to synovial membrane volume determination by magnetic resonance imaging: manual versus automated segmentation. Br J Rheumatol 1997, 36:1116–1177.CrossRefGoogle Scholar
  27. 27.
    Eckstein F, Heudorfer L, Faber S, et al.: Long term and resegmentation precision of quantitative cartilage MR imaging (qMRI). Osteoarthritis Cartilage 2002, 10:922–928.PubMedCrossRefGoogle Scholar
  28. 28.
    Graichen H, Eisenhart-Rothe R, Vogl T, et al.: Quantitative assessment of cartilage status in osteoarthritis by quantitative magnetic resonance imaging. Arthritis Rheum 2004, 50:811–817.PubMedCrossRefGoogle Scholar
  29. 29.
    Tamez-Pena J, Totterman S, Parker K: The integration of automatic segmentation and motion tracking for 4D reconstruction and visualization of musculoskeletal structures. In Proceedings of the IEEE Workshop in Biomedical Image Analysis. Santa Barbara; 1998:154-163.Google Scholar
  30. 30.
    Tamez-Pena J, Totterman S, Parker K: MRI isotropic reconstruction from orthogonal scans. Proc SPIE 2001, 4322:87- 97. Scholar
  31. 31.
    Savnik A, Malmskov H, Thomsen H, et al.: MRI of the wrist and finger joints in inflammatory joint diseases at 1-year interval. MRI features to predict bone erosions. Eur Radiol 2002, 12:1203–1210.PubMedCrossRefGoogle Scholar
  32. 32.
    Ostergaard M, Hansen M, Stoltenberg M, et al.: Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum 1999, 42:918–929.PubMedCrossRefGoogle Scholar
  33. 33.
    Cicuttini F, Wluka A, Stuckey S: Tibial and femoral cartilage changes in knee osteoarthritis. Ann Rheum 2001, 60:977–980.CrossRefGoogle Scholar
  34. 34.
    Raynold J-P, Kauffman C, Beaudoin G, et al.: Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic knees. Osteoarthritis Cartilage 2003, 11:351–360.CrossRefGoogle Scholar
  35. 35.
    Ritchlin CT, Haas-Smith SA, Shao T, et al.: Etanercept lowers the frequency of circulating osteoclast precursors (OCP) and improves bone marrow edema in patients with erosive psoriatic arthritis [abstract]. Proceedings of the American College of Radiology, October 2003.Google Scholar
  36. 36.
    Antoni C, Dechant C, Hanns-Martin Lorenz, et al.: Openlabel study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation. Arthritis Rheum 2002, 47:506–512.PubMedCrossRefGoogle Scholar
  37. 37.
    Ritchlin CT, Haas-Smith SA, Li P, et al.: Mechanisms of TNF-_- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003, 111:821–831.PubMedCrossRefGoogle Scholar
  38. 38.
    Ross G, Chapman A, Newberg A, Scheller A: Magnetic resonance imaging for the evaluation of acute posterolateral complex injuries if the knee. Am J Sports Med 1997, 25:444–448.PubMedGoogle Scholar
  39. 39.
    Lahm A, Erggelet C, Steinwachs M, Reichelt A: Articular and osseoue lesions in revent ligament tera: arthroscopic changes compared with magnetic resonance imaging findings. Arthroscopy 1998, 14:597–604.PubMedCrossRefGoogle Scholar
  40. 40.
    Su M-Y, Cheung Y-C, Fruehauf J, et al.: Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging 2003, 18:467–477.PubMedCrossRefGoogle Scholar
  41. 41.
    Dennie J, Mandeville J, Boxerman J, Packard S: NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998, 40:793–799.PubMedCrossRefGoogle Scholar
  42. 42.
    Dafni H, Landsman L, Schechter B, et al.: MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by the rapid inactivation of the growth factor. NMR Biomed 2002, 15:120–131.PubMedCrossRefGoogle Scholar
  43. 43.
    Su M-Y, Najafi A, Nalcioglu O: Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn Reson Med 1995, 34:402–411.PubMedCrossRefGoogle Scholar
  44. 44.
    Reece RJ, Canete JD, Parsons WJ, et al.: Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 1999, 42:1481–1484.PubMedCrossRefGoogle Scholar
  45. 45.
    Fearon U, Griosios K, Fraser A, et al.: Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 2003, 30:260–268.PubMedGoogle Scholar
  46. 46.
    Tofts P, Brix G, Buckley D, et al.: Estimating kinetic parameters from dynamic contrast enhanced T1-weighted MRI if a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 1999, 10:223–232.PubMedCrossRefGoogle Scholar
  47. 47.
    Ashton E, Evelhoch J, McShane T: Reducing inter-reader variability in MRI perfusion assessment through automated AIF detection. Proceedings of the International Society of Magnetic Resonance Medicine. Kyoto; 2004:147.Google Scholar
  48. 48.
    Barbu-McInnis M, Tamez-Pena J, Totterman S: Focal cartilage defect progression detection: measurement of precision and variation in natural characteristics of cartilage thickness maps derived from 3D MRI data. Proceedings of the IEEE International Symposium on Biomedical Imaging. Arlington; 2004:840-843.Google Scholar
  49. 49.
    McShane T, Ashton E, Jackson E, et al.: Dynamic contrastenhanced MRI (dceMRI) evaluation of the effects of the VEGF/PDGF receptor tyrosine kinase inhibitor AG-012736 on tumor vasculature in a phase I clinical trial. Proceedings of the International Society of Magnetic Resonance Medicine. Kyoto; 2004:154.Google Scholar

Copyright information

© Current Science Inc. 2004

Authors and Affiliations

  • Saara M. S. Totterman
    • 1
  1. 1.VirtualScopicsLLCRochesterUSA

Personalised recommendations